Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics and IVIG for PANDAS
NCT01769027Phase 2Withdrawn
- Sponsor
- CNS Pharmaceuticals
- Start
- Jun 2013
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 2 trial of benzathine penicillin G, azithromycin, immune globulin in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), sponsored by CNS Pharmaceuticals. Planned start Jun 2013; status: withdrawn.
02
Drugs
benzathine penicillin Gazithromycinimmune globulin
03
Conditions
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)
Beyond the preview
Go deeper on NCT01769027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769027.